erythrosine has been researched along with thromboxane a2 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubyak, GR; Dunn, MJ; Mené, P; Scarpa, A | 1 |
| Ikata, T; Katoh, S; Mitsuhashi, T; Morimoto, K; Tonai, T | 1 |
| Coleman, R; Hammond, TG; Horton, AA; Hutchinson, SM | 1 |
| Bose, R; McNicol, A; Roberts, DE | 1 |
| Berndt, MC; Carrim, N; Cowman, J; Kenny, D; Metharom, P; Walsh, TG | 1 |
5 other study(ies) available for erythrosine and thromboxane a2
| Article | Year |
|---|---|
Regulation of cytosolic pH of cultured mesangial cells by prostaglandin F2 alpha and thromboxane A2.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arginine Vasopressin; Calcium; Cell Line; Cells, Cultured; Cytosol; Dinoprost; Fluoresceins; Fluorescent Dyes; Glomerular Mesangium; Humans; Hydrogen-Ion Concentration; Ionomycin; Kinetics; Male; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Tetradecanoylphorbol Acetate; Thromboxane A2 | 1991 |
Increased production of eicosanoids, TXA2, PGI2 and LTC4 in experimental spinal cord injuries.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Flavonoids; Fluoresceins; Guinea Pigs; Indomethacin; Leukotriene C4; Methacrylates; Radioimmunoassay; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Injuries; Thromboxane A2; Thromboxane-A Synthase | 1994 |
Effects of eicosanoids on parameters in isolated rat hepatocytes and isolated rat hepatocyte couplets: protective effects of eicosanoid receptor antagonists.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cell Membrane; Cells, Cultured; Cholic Acids; Dinoprost; Dinoprostone; Dioxanes; Eicosanoids; Fluoresceins; Liver; Prostaglandin Antagonists; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Rats; Receptors, Eicosanoid; Thromboxane A2; Vasoconstrictor Agents; Xanthenes; Xanthones | 1997 |
Mechanism of collagen activation in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Benzofurans; Blood Platelets; Calcium; Collagen; Dose-Response Relationship, Drug; Egtazic Acid; Ethers, Cyclic; Fluoresceins; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Imidazoles; Inositol 1,4,5-Trisphosphate; Models, Biological; Organic Chemicals; Platelet Activation; Platelet Aggregation; Sodium; Sodium-Calcium Exchanger; Specimen Handling; Temperature; Thromboxane A2; Time Factors; Vasoconstrictor Agents | 2004 |
The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation.
Topics: Animals; Arteries; Carrier Proteins; Fluoresceins; MAP Kinase Signaling System; Membrane Glycoproteins; Mice; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidases; Peptides; Phenothiazines; Platelet Activation; Platelet Membrane Glycoproteins; Reactive Oxygen Species; Thrombosis; Thromboxane A2 | 2014 |